Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra M Sarasohn

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gynecologic Oncology|February 18, 2017
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or lessDennis S Chi, Pedro T Ramirez, Jerrold B Teitcher, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|July 15, 2014
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 8, 2025
A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Kimberly Murphy, Kaothar Oladoja, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gynecologic Oncology|February 18, 2017
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or lessDennis S Chi, Pedro T Ramirez, Jerrold B Teitcher, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|July 15, 2014
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 8, 2025
A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Kimberly Murphy, Kaothar Oladoja, et al.
Pageof 2